Advertisement
News
Subscribe to MDT Magazine News

Researchers link gene mutations to Ebstein's anomaly

February 16, 2011 8:35 am | by EurekAlert | Comments

(Helmholtz Association of German Research Centres) Ebstein's anomaly is a rare congenital valvular heart disease. Now, in patients with this disease, researchers of the Academic Medical Center Amsterdam in the Netherlands, the University of Newcastle, UK and the Max Delbrueck...

TOPICS:

"Manufacturing the Future & #8211; A Documentary" Premiers February 26 at Green Bay Film Festival

February 16, 2011 8:35 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., GREEN BAY, Wis., February 15, 2011 — Is manufacturing dead in Wisconsin? It's a provocative question for any state, as local communities are finding they have to take more responsibility for their own longevity in today's global manufacturing environment....

Syneron turns 4Q profit, international sales grow

February 16, 2011 7:45 am | by The Associated Press | Comments

Syneron Medical Ltd. turned a fourth-quarter profit, as international sales and an acquisition helped the Israeli company's revenue more than triple from the same quarter of 2009.Syneron said Wednesday it earned $8.4 million, or 24 cents per share, in the three months that ended Dec. 31. That...

Advertisement

WellCare 4Q profit soars as benefits expense sinks

February 16, 2011 7:45 am | by The Associated Press | Comments

Government health insurance provider WellCare Health Plans Inc. saw its fourth-quarter earnings more than double, as a 21 percent drop in expenses for claims helped outweigh declines in premiums and membership.The Tampa, Fla., company said Wednesday it earned $26.1 million, or 61 cents per...

AT & T Connected Vitality GlowCaps Wins 2011 Global Mobile Award

February 16, 2011 7:32 am | by Bio-Medicine.Org | Comments

DALLAS, Feb. 16, 2011 /- Vitality, Inc. and AT&T* have been honored with a prestigious 2011 Global Mobile Award for AT&T connected Vitality GlowCaps . The Global Mobile Awards recognize excellence and innovation in mobile products, services and initiatives across the global mobile...

TOPICS:

Zimmer Continuum® Acetabular System Becomes Zimmer's Best Selling Hip Construct

February 16, 2011 7:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Feb. 16, 2011 /- Zimmer Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a leader in musculoskeletal care, today announced that its Continuum® Acetabular System recently became the Company's best-selling hip construct.  Introduced in late 2009, the Continuum Acetabular System...

TOPICS:

Zimmer Showcases Newly Acquired Line of Surgical Power Tools at 2011 AAOS Annual Meeting

February 16, 2011 7:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Feb. 16, 2011 /- Zimmer Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a global leader in musculoskeletal care, today announced it will showcase a new line of orthopaedic surgical power tools as part of the Company's exhibit at the 2011 American Academy of Orthopaedic Surgeons (AAOS)...

TOPICS:

Jardogs' FollowMyHealthâ„¢ Universal Health Record Receives ONC-ATCB Certification

February 16, 2011 7:32 am | by Bio-Medicine.Org | Comments

SPRINGFIELD, Ill., Feb. 16, 2011 /- Jardogs announced that its Universal Health Record (UHR) FollowMyHealth™ v1.0 is 2011/2012 compliant and was certified as an EHR Module on January 27th, 2011 by the Certification Commission for Health Information Technology (CCHIT®), an...

TOPICS:
Advertisement

AirPal Receives Patent for Inflatable Patient Positioning Systems

February 16, 2011 7:31 am | by Bio-Medicine.Org | Comments

NORTH WALES, Pa., Feb. 16, 2011 /- AirPal, a medical device manufacturer headquartered in North Wales, Pennsylvania, has received notification of allowance from the U.S. Patent Office for its modular system of inflatable devices used to position patients for situations such as difficult...

TOPICS:

Triad Sterile Lubricating Jelly: Recall - Product May Not Be Sterile

February 16, 2011 6:34 am | by U.S. Food & Drug Administration | Comments

Patients who are immuno-compromised may be at potential risk for infection.

Gen-Probe 4Q profit rises 13 percent

February 16, 2011 4:45 am | by The Associated Press | Comments

Diagnostic test maker Gen-Probe Inc. said Wednesday its profit grew 13 percent in the fourth quarter as its gross margins improved and costs decreased, offsetting lower revenue.The company also said that it approved the repurchase of up to $150 million in stock over the next year. The company...

Hospitalists at New England Baptist Hospital Choose MedAptus

February 16, 2011 4:35 am | by Bio-Medicine.Org | Comments

BOSTON, Feb. 16, 2011 /- MedAptus®, the market leader for charge capture technologies, today announced that New England Baptist Hospital (NEBH) has selected the company's Professional Intelligent Charge Capture technology for its inpatient medicine providers. The NEBH hospitalist...

TOPICS:

Valeant Pharmaceuticals to Present at RBC Capital Markets' 2011 Healthcare Conference

February 16, 2011 4:34 am | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, Feb. 16, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) today announced members of its senior management team will make a presentation at the RBC Capital Markets' 2011 Healthcare Conference on Thursday, March 3, 2011, at 11:00 a.m. ET....

TOPICS:

New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review

February 16, 2011 4:34 am | by Bio-Medicine.Org | Comments

ALBUQUERQUE, N.M., Feb. 16, 2011 /- New Mexico Software, Inc. (OTC Bulletin Board: NMXC ), a developer of medical IT services and solutions that enable improved and faster communication within the healthcare community, announced today the company will begin providing second opinion...

TOPICS:

CSL Behring Marks World Hemophilia Day with Coagulation Factor Donation to World Federation of Hemophilia

February 16, 2011 4:33 am | by Bio-Medicine.Org | Comments

KING OF PRUSSIA, Pa. and MONTREAL, Feb. 16, 2011 /- As a means of aiding the World Federation of Hemophilia's (WFH) progress in improving the diagnosis and treatment of hemophilia in developing countries through its Global Alliance for Progress (GAP) program, CSL Behring has committed to...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading